(Q41503446)

1 October 2017

title

Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma (English)

1 reference

1 October 2017

7

Yaron M Rabinowitz

1 reference

1 October 2017

Chen Cai

1

1 reference

1 October 2017

Yi-Fan Xu

2

1 reference

1 October 2017

Zhen-Jie Wu

3

1 reference

1 October 2017

Qin Dong

4

1 reference

1 October 2017

Min-Yu Li

5

1 reference

1 October 2017

Jason C Olson

6

1 reference

1 October 2017

Lin-Hui Wang

8

1 reference

1 October 2017

Yinghao Sun

9

1 reference

1 October 2017

publication date

8 August 2015

1 reference

1 October 2017

published in

World Journal of Urology

1 reference

1 October 2017

volume

34

1 reference

1 October 2017

issue

4

1 reference

1 October 2017

page(s)

561-567

1 reference

The role of metastasectomy in renal cell carcinoma in the era of targeted therapy

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Expression of Tim-3 is transiently increased before development of anterior chamber-associated immune deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Dysregulated T cell expression of TIM3 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Tim-3, a negative regulator of anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

TIM-family proteins inhibit HIV-1 release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

Tumour and patient factors in renal cell carcinoma-towards personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1656-7

T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and renal cell carcinoma

21 January 2018

1 reference

12 December 2020

The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas.

1 reference

12 December 2020

Up-regulation of Tim-3 on T cells during acute simian immunodeficiency virus infection and on antigen specific responders

1 reference

12 December 2020

Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity

1 reference

12 December 2020

10.1007/S00345-015-1656-7

Identifiers

DOI

1 reference

Dimensions Publication ID

1 October 2017

1052650610

0 references

1 reference